Dominari Holdings Inc.
DOMHNasdaq
$2.76
↓ -1.8%Jul 17 close · end-of-day
Price
1Y↓ -38.0%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$49.9M
Enterprise Value
$22.4M
P/E
—
P/S
0.3
P/B
1.6
EV/EBITDA
—
PEG
—
FCF Yield
—
Dividend Yield
—
Revenue (TTM)
$151.7M
Net Income (TTM)
-$47.3M
Free Cash Flow (TTM)
—
Gross Margin
—
Operating Margin
-39.9%
Net Margin
-31.2%
ROE
-149.7%
ROIC
-1156.0%
Debt / Equity
—
Net Cash
$27.5M
Return 1Y
-39.3%
Company profile
AIkido Pharma Inc. focuses on developing small-molecule anti-cancer therapeutics. Its pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. The company is also developing an antiviral platform that inhibits replication of viruses.
- CEO
- Anthony C. Hayes
- Sector
- Finance, Insurance, And Real Estate
- Industry
- Trading
- Employees
- 4
- Headquarters
- New York
- Website
- aikidopharma.com
Management & directors
- Hayes AnthonyCEO
- Wool Kyle MichaelPresident
- Ledwick Tim SChief Financial Officer
- Devall Christopher FranklinCOO
Roles derived from SEC Form 4 filings.
Earnings
DOMH Q1 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue$35.8M↑ +394.5%
Diluted EPS-$3.17↑ +5.0%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | — | — | — | $2.0M | $21.0M | $123.1M |
| Gross profit | — | — | — | — | — | — |
| Operating income | -$6.5M | -$9.4M | -$14.3M | -$21.8M | -$8.7M | -$55.7M |
| Net income | -$12.3M | -$7.2M | -$22.1M | -$22.9M | -$14.7M | -$22.4M |
| Diluted EPS | — | -$1.48 | -$4.91 | -$4.38 | -$2.38 | -$1.57 |
| Operating cash flow | -$4.0M | -$6.6M | -$10.6M | -$22.2M | -$16.7M | $22.7M |
| Free cash flow | — | — | — | -$22.7M | — | — |
| Gross margin | — | — | — | — | — | — |
| Operating margin | — | — | — | -1069.0% | -41.5% | -45.3% |
| Net margin | — | — | — | -1122.2% | -70.1% | -18.2% |
| Line item | Q '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $6.2M | $4.0M | $9.4M | $7.2M | $34.1M | $50.8M | $30.9M | $35.8M |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | -$2.7M | -$3.2M | $35,000.00 | -$32.9M | -$19.4M | -$1.6M | -$1.8M | -$37.6M |
| Net income | -$6.1M | -$4.2M | $1.1M | -$32.5M | $16.6M | $125.2M | -$131.8M | -$57.4M |
| Diluted EPS | -$1.01 | -$0.67 | $0.21 | -$3.02 | $1.12 | $7.27 | -$6.94 | -$3.17 |
| Operating cash flow | $1.4M | -$4.7M | -$4.8M | $1.2M | -$353,000.00 | -$4.9M | $26.8M | -$28.9M |
| Free cash flow | — | — | — | — | — | — | — | — |
| Gross margin | — | — | — | — | — | — | — | — |
| Operating margin | -44.3% | -79.1% | 0.4% | -454.2% | -57.0% | -3.1% | -5.9% | -105.1% |
| Net margin | -99.1% | -104.2% | 11.4% | -448.7% | 48.7% | 246.4% | -425.8% | -160.2% |
Company news
Jun 16, 2026
Jun 15, 2026
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-03-04 | Hayes Anthony· CEO | Award | 3,000,000 | — | — | filing |
| 2026-03-04 | Wool Kyle Michael· President | Award | 3,000,000 | — | — | filing |
| 2026-01-09 | LEDWICK TIM S· Chief Financial Officer | Award | 316,346 | — | — | filing |
| 2026-01-09 | Haug Kyle | Award | 25,000 | — | — | filing |
| 2026-01-09 | Blattner Gregory James | Award | 25,000 | — | — | filing |
| 2026-01-09 | Parsley Brian Keith | Award | 25,000 | — | — | filing |
| 2025-12-11 | Devall Christopher Franklin· COO | Award | 10,000 | — | — | filing |
| 2025-12-08 | Devall Christopher Franklin· COO | Sale | 45,000 | $3.85 | $173,061.00 | filing |
| 2025-12-08 | Devall Christopher Franklin· COO | Sale | 45,000 | $3.85 | $173,061.00 | filing |
| 2025-12-08 | Wool Kyle Michael· President | Buy | 25,000 | $3.87 | $96,797.50 | filing |
| 2025-12-08 | Hayes Anthony· CEO | Buy | 23,000 | $3.87 | $89,053.70 | filing |
| 2025-12-05 | Devall Christopher Franklin· COO | Sale | 140,000 | $3.82 | $534,254.00 | filing |
| 2025-12-04 | Devall Christopher Franklin· COO | Sale | 40,000 | $4.21 | $168,548.00 | filing |
| 2025-12-03 | Devall Christopher Franklin· COO | Sale | 40,000 | $4.22 | $168,604.00 | filing |
| 2025-09-23 | Blattner Gregory James | Sale | 14,409 | — | — | filing |
Latest 15 transactions.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.